Recall data checked 1 hour ago

Loading recalls…

Loading…

The Recall Registry is not a government service and does not issue recalls. We gather published recall notices from the U.S. Consumer Product Safety Commission, the U.S. Food and Drug Administration and the National Highway Traffic Safety Administration, and rewrite them in plain language. Always confirm the details with the issuing agency using the link on each recall page.

Home All recalls Services For shops For families Your account About Privacy Terms CPSC FDA NHTSA

Home › All recalls › Prescription medicine

Prescription medicine recalls

Prescription drugs recalled for contamination, potency or labelling.

Search recalls by product, brand or category

Or try another category

Everything

Children

Sleep & nursery280 Car seats254 Formula & baby food232 Children's medicine178 Swings & bouncers126 Nursery furniture324 Toys & play867 Strollers & carriers156 Clothing & sleepwear633

Adults & seniors

Prescription medicine2,102 Over-the-counter & supplements425 Mobility & home health186

Food & drink

Family food1,442

Pets

Pet food & products16

Home & car

Cleaning & chemicals273 Appliances & tools1,404 Furniture & furnishings580 Cars & vehicles12,380 Everything else2,332

Highest riskSeriousWorth checkingLabelling issueTap any recall for the hazard and what to do

2,102 recalls · newest first

Food & drug recall · FDAOctober 28, 2025Serious

SUN PHARMACEUTICAL INDUSTRIES INC — Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only

Prescription medicine · SUN PHARMACEUTICAL INDUSTRIES INC · N/A affected

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…

Food & drug recall · FDAOctober 28, 2025Serious

SUN PHARMACEUTICAL INDUSTRIES INC — Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only

Prescription medicine · SUN PHARMACEUTICAL INDUSTRIES INC · N/A affected

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…

Food & drug recall · FDAOctober 28, 2025Serious

SUN PHARMACEUTICAL INDUSTRIES INC — Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only

Prescription medicine · SUN PHARMACEUTICAL INDUSTRIES INC · N/A affected

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…

Food & drug recall · FDAOctober 28, 2025Serious

SUN PHARMACEUTICAL INDUSTRIES INC — Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only

Prescription medicine · SUN PHARMACEUTICAL INDUSTRIES INC · N/A affected

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…

Food & drug recall · FDAOctober 28, 2025Serious

Agebox — Agebox iKids-Growth (Day Formula) capsules, 60-count bottles

Prescription medicine · Agebox · 665 bottles affected

Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Food & drug recall · FDAOctober 27, 2025Serious

Otsuka ICU Medical LLC — 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37

Prescription medicine · Otsuka ICU Medical LLC · 509,360 100 mL bags affected

Lack of Assurance of Sterility: Potential for flexible container leaks.

Food & drug recall · FDAOctober 24, 2025Serious

Cipla USA, Inc. — Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only

Prescription medicine · Cipla USA, Inc. · 1180 boxes affected

Failed stability specifications: Out of specification for hardness test

Food & drug recall · FDAOctober 24, 2025Serious

Cipla USA, Inc. — Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only

Prescription medicine · Cipla USA, Inc. · N/A affected

Failed stability specifications: Out of specification for hardness test

Food & drug recall · FDAOctober 23, 2025Serious

Zydus Pharmaceuticals (USA) Inc — Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 6838

Prescription medicine · Zydus Pharmaceuticals (USA) Inc · 36,624 bottles affected

Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate…

Food & drug recall · FDAOctober 22, 2025Serious

Zydus Pharmaceuticals (USA) Inc — clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottles (NDC 16714-850-01), b) 90-count bottles (NDC 16714-850-02), c) 100-count bottles (NDC 16714-850-03), Rx only

Prescription medicine · Zydus Pharmaceuticals (USA) Inc · N/A affected

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…

Food & drug recall · FDAOctober 22, 2025Serious

Zydus Pharmaceuticals (USA) Inc — clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC 16714-849-02), c) 100-count bottles (NDC 16714-849-03), Rx only

Prescription medicine · Zydus Pharmaceuticals (USA) Inc · N/A affected

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…

Food & drug recall · FDAOctober 22, 2025Serious

Zydus Pharmaceuticals (USA) Inc — clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottles (NDC 16714-851-01), b) 90-count bottles (NDC 16714-851-02), c) 100 capsules, NDC 16714-851-03 Rx only

Prescription medicine · Zydus Pharmaceuticals (USA) Inc · N/A affected

cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above…

Food & drug recall · FDAOctober 21, 2025Serious

Bristol-Myers Squibb Company — Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11

Prescription medicine · Bristol-Myers Squibb Company · 12,778 total vials affected

Lack of Assurance of Sterility.

Food & drug recall · FDAOctober 20, 2025Highest risk

ANTHONY TRINH, 123Herbals LLC — SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Prescription medicine · ANTHONY TRINH, 123Herbals LLC · N/A affected

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Food & drug recall · FDAOctober 20, 2025Labelling issue

Imprimis NJOF, LLC — Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852

Prescription medicine · Imprimis NJOF, LLC · 67,091 bottles affected

Subpotent Drug

Food & drug recall · FDAOctober 20, 2025Serious

Golden State Medical Supply Inc. — NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only

Prescription medicine · Golden State Medical Supply Inc. · 24,869 bottles affected

Failed Dissolution Specifications

Food & drug recall · FDAOctober 16, 2025Serious

Amerisource Health Services LLC — Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only

Prescription medicine · Amerisource Health Services LLC · 1,818 cartons affected

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA)…

Food & drug recall · FDAOctober 16, 2025Serious

Amerisource Health Services LLC — Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only

Prescription medicine · Amerisource Health Services LLC · 3,410 cartons affected

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA)…

Food & drug recall · FDAOctober 16, 2025Serious

Amerisource Health Services LLC — Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only

Prescription medicine · Amerisource Health Services LLC · 1,970 cartons affected

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA)…

Food & drug recall · FDAOctober 15, 2025Serious

ProRx LLC — Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-04

Prescription medicine · ProRx LLC · 8,400 vials affected

Lack of Assurance of Sterility

← NewerPage 34 of 106Older →